[HTML][HTML] 治疗前后NLR 和PLR 对进展期非小细胞肺癌一线化疗疗效及预后的预测价值
易福梅， 顾阳春， 陈森， 刘燕娥， 尹文琤… - Chinese Journal of …, 2018 - ncbi.nlm.nih.gov
背景与目的中性粒细胞淋巴细胞比值(neutrophil-to-lymphocyte ratio, NLR)
和血小板淋巴细胞比值(platelet-to-lymphocyte ratio, PLR) 是机体系统性炎症的体现 …
和血小板淋巴细胞比值(platelet-to-lymphocyte ratio, PLR) 是机体系统性炎症的体现 …
Impact of the pretreatment or posttreatment NLR and PLR on the response of first line chemotherapy and the outcomes in patients with advanced non-small cell lung …
YI Fumei, GU Yangchun, C Sen, LIU Yan'e… - Zhongguo fei ai …, 2018 - search.proquest.com
背景与目的 中性粒细胞淋巴细胞比值 (neutrophil-to-lymphocyte ratio, NLR)
和血小板淋巴细胞比值 (platelet-to-lymphocyte ratio, PLR) 是机体系统性炎症的体现 …
和血小板淋巴细胞比值 (platelet-to-lymphocyte ratio, PLR) 是机体系统性炎症的体现 …
[HTML][HTML] Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in non-small cell lung cancer
M Bayraktaroglu, BP Yildiz - Medicine, 2023 - journals.lww.com
Non-small cell lung cancer (NSCLC) is characterized by diagnosis at an advanced stage,
low rate of operability and poor survival. Therefore, there is a need for a biomarker in …
low rate of operability and poor survival. Therefore, there is a need for a biomarker in …
Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line …
D Guo, M Li, D Chen, W Jing, H Zhu, L Fu, L Kong… - Future …, 2018 - Taylor & Francis
Aim: We aimed to investigate the prognostic impact of the neutrophil-to-lymphocyte ratio
(NLR) and platelet-to-lymphocyte ratio (PLR) in advanced non-small-cell lung cancer treated …
(NLR) and platelet-to-lymphocyte ratio (PLR) in advanced non-small-cell lung cancer treated …
[PDF][PDF] 动态监测NLR, PLR 变化与晚期肺腺癌一线化疗疗效及预后关系
李曦颖， 黄礼年 - 蚌埠医学院学报, 2020 - xuebao.bbmc.edu.cn
目的: 探讨中性粒细胞淋巴细胞比率(NLR) 及血小板淋巴细胞比率(PLR) 的动态变化对晚期肺腺
癌病人化疗疗效及生存期的预测价值. 方法: 回顾性分析193 例经一线化疗的晚期肺腺癌病人 …
癌病人化疗疗效及生存期的预测价值. 方法: 回顾性分析193 例经一线化疗的晚期肺腺癌病人 …
Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line …
Y Yao, D Yuan, H Liu, X Gu, Y Song - Cancer immunology …, 2013 - Springer
Background Neutrophil to lymphocyte ratio (NLR) has been shown to be a prognosis
indicator in different types of cancer. We aimed to investigate the association between NLR …
indicator in different types of cancer. We aimed to investigate the association between NLR …
Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non‐small cell lung cancer patients
G Wu, Y Yao, C Bai, J Zeng, D Shi, X Gu, X Shi… - Thoracic …, 2015 - Wiley Online Library
Background The neutrophil to lymphocyte ratio (NLR) was recently shown to be a
remarkable prognostic factor in tumors. Moreover, some studies have indicated that the …
remarkable prognostic factor in tumors. Moreover, some studies have indicated that the …
NLR, PLR, CEA 在晚期非小细胞肺癌预后中的价值
鲍欣然， 哈敏文 - 临床荟萃, 2021 - huicui.hebmu.edu.cn
目的探讨中性粒细胞与淋巴细胞比值(NLR), 血小板与淋巴细胞比值(PLR), 癌胚抗原(CEA)
在晚期非小细胞肺癌(NSCLC) 患者中的预后价值. 方法将晚期NSCLC 患者135 …
在晚期非小细胞肺癌(NSCLC) 患者中的预后价值. 方法将晚期NSCLC 患者135 …
The neutrophil to lymphocyte ratio may predict benefit from chemotherapy in lung cancer
D Liu, J Jin, L Zhang, L Li, J Song, W Li - Cellular Physiology and …, 2018 - karger.com
Abstract Background/Aims: The objectives of this study were to evaluate the impact of the
neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) on overall …
neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) on overall …
[HTML][HTML] NLR 动态变化对SCLC 化疗患者预后的影响
李武军， 陈志军， 张斌杰， 陈城， 李予林 - 实用肿瘤杂志, 2019 - xml-data.org
目的探讨中性粒细胞与淋巴细胞比值(neutrophil-to-lymphocyte ratio, NLR)
动态变化对经化疗治疗的小细胞肺癌(small cell lung cancer, SCLC) 患者的临床特征和预后的 …
动态变化对经化疗治疗的小细胞肺癌(small cell lung cancer, SCLC) 患者的临床特征和预后的 …